The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global proteinase K market is expected to exhibit a CAGR of 7.33% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Proteinase K is a serine alkaline protease that is widely utilized in protein digest. It is also used in molecular biology to remove contamination from nuclear acid preparations. Moreover, as it assists in the removal of endotoxins bound to cationic patients, such as ribonuclease A and lysozyme, determination of enzyme localization on membranes, and digestion of proteins from brain tissue samples, its demand is escalating around the world.
A considerable rise in the demand for nucleic acid purification, tissue digestion and improved cloning efficiency represents one of the primary factors strengthening the global market growth. The increasing prevalence of infectious diseases and the wide applicability of proteinase K in diagnosing these diseases is also fueling the growth of the market. Apart from this, as the incubation of DNA from the Hepatitis B virus (HBV) with proteinase K aids in efficient DNA isolation, its demand is rising across the globe. It also finds extensive application in the treatment of paraffin-embedded sections of tissues during antibody labeling and isolation of mitochondria from hepatic cells. Additionally, it is used during the polymerase chain reaction (PCR) purification for a wide range of in-vitro diagnostics (IVD) applications. Furthermore, the sudden outbreak of the coronavirus disease (COVID-19) is positively influencing the market growth as proteinase K is employed in the pre-treatment to detect the SARS-CoV-2 in samples collected without the need for RNA extraction.
IMARC Group provides an analysis of the key trends in each sub-segment of the global proteinase K market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on therapeutic area, type, form and end user.
Breakup by Therapeutic Area:
Breakup by Type:
Breakup by Form:
Breakup by End User:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Advanced Enzymes Technologies Ltd., American Laboratories, Amicogen Inc., BBI Solutions, Biocatalysts Ltd., Codexis Inc., Dyadic International Inc., F. Hoffmann-La Roche Ltd. (Roche Ag), Merck KGaA, Qiagen N.V. and Thermo Fisher Scientific Inc.
|Base Year of the Analysis||2021|
|Segment Coverage||Therapeutic Area, Form, Type, End User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Advanced Enzymes Technologies Ltd., American Laboratories, Amicogen Inc., BBI Solutions, Biocatalysts Ltd., Codexis Inc., Dyadic International Inc., F. Hoffmann-La Roche Ltd. (Roche Ag), Merck KGaA, Qiagen N.V. and Thermo Fisher Scientific Inc.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at